Page last updated: 2024-08-17

nad and Degenerative Diseases, Central Nervous System

nad has been researched along with Degenerative Diseases, Central Nervous System in 63 studies

Research

Studies (63)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (17.46)29.6817
2010's26 (41.27)24.3611
2020's26 (41.27)2.80

Authors

AuthorsStudies
Cao, Y; Lin, X; Liu, F; Pan, M; Sun, G; Tan, X; Zhao, K; Zhao, Q; Zheng, L1
Beura, S; Ghosh, R; Mishra, P; Modak, R1
Braidy, N; Helman, T1
Chen, X; Gao, M; Hu, C; Li, W; Zhou, Y1
Bommireddipalli, S; Bournazos, AM; Christodoulou, J; Cooper, ST; Garza, D; Gooley, S; Gunanayagam, K; Jones, DL; Linster, CL; Lunke, S; McLean, CA; Naidoo, P; Patraskaki, M; Rajasekaran, M; Sebire, D; Semcesen, LN; Sikora, T; Stroud, DA; Van Bergen, NJ; Wallis, M; Walvekar, AS; Warmoes, MO1
Duarte-Pereira, S; Matos, S; Oliveira, JL; Silva, RM1
Borén, J; Doganay, HL; Jin, H; Li, X; Mardinoglu, A; Nielsen, J; Ozturk, G; Turkez, H; Uhlén, M; Yang, H; Zhang, C1
Baur, JA; Bhasin, S; Migaud, M; Musi, N; Seals, D1
Lu, HC; Park, JH; Yang, S1
Green, M; Griffiths, JC; Ho, E; Huber, LG; Neufeld, LM; Obeid, R; Stout, M; Tzoulis, C1
Fang, EF; Lautrup, S; Mattson, MP; Sinclair, DA1
Fang, F; Gong, S; Li, J; Prokisch, H; Ren, X; Stenton, SL; Zhou, J1
Braidy, N; Liu, Y1
Castro-Portuguez, R; Sutphin, GL1
Bressac, L; Guerreiro, S; Privat, AL; Toulorge, D1
Chronister, WD; Fragola, G; Li, Z; Mabb, AM; Mao, H; McConnell, MJ; Niehaus, JK; Simon, JM; Taylor-Blake, B; Yuan, H; Zylka, MJ1
Christodoulou, J; Linster, CL; Van Bergen, NJ1
Abe, J; Borna, NN; Furukawa, T; Fushimi, T; Imai-Okazaki, A; Kishita, Y; Murayama, K; Ogawa-Tominaga, M; Ohtake, A; Okazaki, Y; Takeda, A1
Berger, NA; Kincaid, JW1
Jeong, H; Kim, KW; Lee, Y; Park, KH1
Musiek, ES; Smith, SK1
Gong, Z; Jiao, F1
Gao, W; Huang, C; Huber, PE; Li, C; Shen, G; Xie, N; Zhang, L; Zhou, X; Zou, B1
McCully, KS1
Kratz, EM; Kubis-Kubiak, A; Piwowar, A; Sołkiewicz, K1
Brazill, JM; Li, C; Zhai, RG; Zhu, Y1
Osborne, B; Samsudeen, AF; Sultani, G; Turner, N1
Hoek, JB; Rottenberg, H1
Nakagawa, T; Okabe, K; Yaku, K1
Ahting, U; Baple, E; Baptista, J; Becker-Kettern, J; Christodoulou, J; Conrotte, JF; Daubeney, P; Ellard, S; Ellaway, C; Girisha, KM; Guo, Y; Hakonarson, H; Homfray, T; Kay, DP; Kovacs-Nagy, R; Kremer, LS; Lewis, LES; Linster, CL; Massey, S; Montoya, J; Paczia, N; Power, R; Prelog, K; Pritsch, M; Procopis, P; Prokisch, H; Pyle, A; Rankin, J; Ruiz-Pesini, E; Santra, S; Shukla, A; Taylor, RW; Thorburn, DR; Van Bergen, NJ; Wakeling, M1
Klimova, N; Kristian, T1
Savitz, J1
Beal, MF; Lloret, A1
Hikosaka, K; Nakagawa, T; Okabe, K; Yaku, K1
Guarente, L; Herskovits, AZ1
Alleaume-Butaux, A; Brugg, B; Deleglise, B; Hjorth, JJ; Lassus, B; Peyrin, JM; Schneider, B; Soubeyre, V; Vignes, M; Viovy, JL1
Di Stefano, G; Manerba, M; Vettraino, M1
Sibon, OC; Srinivasan, B1
Gray, JJ; Linseman, DA; Stankiewicz, TR; Winter, AN1
Harrington, M1
Fishman, PS; Kristian, T; Long, AN; Owens, K; Schlappal, AE; Schuh, RA1
Auwerx, J; Cantó, C; Menzies, KJ1
Verdin, E1
Chang, B; Lu, S; Peng, J; Quan, Q; Wang, Y1
Scheibye-Knudsen, M1
Haigis, MC; Santos, D; van de Ven, RAH1
Fülöp, F; Klivényi, P; Toldi, J; Vámos, E; Vécsei, L; Zádori, D1
Aljada, A; Dong, L; Mousa, SA1
Balan, I; Kristian, T; Onken, M; Schuh, R1
Chertov, AO; Couron, D; Holzhausen, L; Hurley, JB; Kuok, IT; Linton, JD; Parker, E; Sadilek, M; Sweet, IR1
Braidy, N; Grant, R; Guillemin, GJ; Massudi, H1
Fernandez, E; Goldstein, DS; Martinez, PA; Strong, R; Sullivan, P; Wey, MC1
Giaume, C; Orellana, JA; Sáez, JC; von Bernhardi, R1
Bedalov, A; Simon, JA1
Buck, HM1
Adam-Vizi, V; Tretter, L1
Kennedy, BK; Longo, VD1
Belenky, P; Bogan, KL; Brenner, C1
Grant, RS; Jayasena, T; Keerthisinghe, N; Smythe, GA; Solaja, I1
Forouhar, F; Khan, JA; Tao, X; Tong, L1
Auwerx, J; Dali-Youcef, N; Froelich, S; Koehl, C; Lagouge, M; Schoonjans, K1
Darlington, LG; Forrest, CM; Mackay, GM; Stone, TW; Stoy, N1
Ying, W1

Reviews

43 review(s) available for nad and Degenerative Diseases, Central Nervous System

ArticleYear
Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders.
    Drugs & aging, 2023, Volume: 40, Issue:1

    Topics: Aging; Dietary Supplements; Humans; NAD; Neurodegenerative Diseases; Niacinamide; Nicotinamide Mononucleotide

2023
NMNAT2: An important metabolic enzyme affecting the disease progression.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 158

    Topics: Axons; Disease Progression; Humans; NAD; Neurodegenerative Diseases; Nicotinamide-Nucleotide Adenylyltransferase; Wallerian Degeneration

2023
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns.
    Endocrine reviews, 2023, 11-09, Volume: 44, Issue:6

    Topics: Aged; Aging; Biology; Fatty Liver; Humans; NAD; Neurodegenerative Diseases

2023
Axonal energy metabolism, and the effects in aging and neurodegenerative diseases.
    Molecular neurodegeneration, 2023, 07-20, Volume: 18, Issue:1

    Topics: Aging; Animals; Axons; Energy Metabolism; Glucose; Humans; NAD; Neurodegenerative Diseases

2023
NAD
    Cell metabolism, 2019, 10-01, Volume: 30, Issue:4

    Topics: Aging; Animals; Brain; Cell Line; Humans; Mice; NAD; Neurodegenerative Diseases; Neurons; Rats

2019
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.
    Experimental gerontology, 2020, Volume: 132

    Topics: Aging; Animals; Humans; Inflammation; Mice; NAD; Neurodegenerative Diseases; Niacinamide; Nicotinamide Mononucleotide; Oxidative Stress; Pyridinium Compounds; Rats; Risk Assessment

2020
Kynurenine pathway, NAD
    Experimental gerontology, 2020, Volume: 132

    Topics: Aging; Animals; Brain; Humans; Kynurenine; Longevity; Metabolic Networks and Pathways; Mice; Mitochondria; Mitophagy; NAD; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Tryptophan

2020
CD38 in Neurodegeneration and Neuroinflammation.
    Cells, 2020, 02-18, Volume: 9, Issue:2

    Topics: ADP-ribosyl Cyclase 1; Aging; Animals; Astrocytes; Brain; Humans; Membrane Glycoproteins; Mice; Mice, Knockout; Microglia; NAD; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Neuroprotective Agents

2020
Effects of NAD
    Biomolecules, 2020, 07-02, Volume: 10, Issue:7

    Topics: Animals; Caenorhabditis elegans; Disease Models, Animal; NAD; Nerve Regeneration; Neurodegenerative Diseases; Neuroprotection; Neurotoxins; Signal Transduction

2020
Impact of circadian and diurnal rhythms on cellular metabolic function and neurodegenerative diseases.
    International review of neurobiology, 2020, Volume: 154

    Topics: Chronobiology Disorders; Humans; Mitochondria; NAD; Neurodegenerative Diseases; Sirtuins; Sleep Wake Disorders

2020
The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases.
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Animals; Brain Injuries, Traumatic; Humans; NAD; Neurodegenerative Diseases; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Resveratrol; Sirtuin 1; Toll-Like Receptors

2020
NAD
    Signal transduction and targeted therapy, 2020, 10-07, Volume: 5, Issue:1

    Topics: Aging; Cyclic ADP-Ribose; Humans; Metabolic Diseases; NAD; NADP; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction

2020
Chemical Pathology of Homocysteine VIII. Effects of Tocotrienol, Geranylgeraniol, and Squalene on Thioretinaco Ozonide, Mitochondrial Permeability, and Oxidative Phosphorylation in Arteriosclerosis, Cancer, Neurodegeneration and Aging.
    Annals of clinical and laboratory science, 2020, Volume: 50, Issue:5

    Topics: Aging; Animals; Arteriosclerosis; Cholesterol; Diterpenes; Homocysteine; Humans; Mitochondria; NAD; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Phosphorylation; Permeability; Squalene; Tocotrienols; Vitamin B 12

2020
Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators.
    International journal of molecular sciences, 2021, Jan-10, Volume: 22, Issue:2

    Topics: Gene Expression Regulation; Humans; NAD; Neoplasms; Neurodegenerative Diseases; Oxidative Stress; Sirtuins

2021
NMNAT: It's an NAD
    Current opinion in genetics & development, 2017, Volume: 44

    Topics: Amide Synthases; Humans; Molecular Chaperones; NAD; Neurodegenerative Diseases; Neurons; Nicotinamide-Nucleotide Adenylyltransferase

2017
NAD
    Journal of neuroendocrinology, 2017, Volume: 29, Issue:10

    Topics: Aging; Animals; Homeostasis; Humans; NAD; Neoplasms; Neurodegenerative Diseases

2017
The path from mitochondrial ROS to aging runs through the mitochondrial permeability transition pore.
    Aging cell, 2017, Volume: 16, Issue:5

    Topics: Aging; Animals; Calcium; Caloric Restriction; Cyclophilins; Gene Expression Regulation; Humans; Ischemic Preconditioning; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; NAD; Neurodegenerative Diseases; Oxidation-Reduction; Reactive Oxygen Species; Reperfusion Injury

2017
NAD metabolism: Implications in aging and longevity.
    Ageing research reviews, 2018, Volume: 47

    Topics: Aging; Animals; Humans; Longevity; NAD; Neoplasms; Neurodegenerative Diseases

2018
Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism.
    Neurochemical research, 2019, Volume: 44, Issue:10

    Topics: Animals; Brain; Humans; Hydrolases; Mitochondria; NAD; Neurodegenerative Diseases; Niacinamide; Nicotinamide Mononucleotide

2019
The kynurenine pathway: a finger in every pie.
    Molecular psychiatry, 2020, Volume: 25, Issue:1

    Topics: Aging; Animals; Energy Metabolism; Humans; Kynurenine; Mental Disorders; NAD; Neurodegenerative Diseases; Signal Transduction; Tryptophan

2020
PGC-1α, Sirtuins and PARPs in Huntington's Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All.
    Neurochemical research, 2019, Volume: 44, Issue:10

    Topics: Animals; Humans; Mitochondria; NAD; Neurodegenerative Diseases; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Poly (ADP-Ribose) Polymerase-1; Sirtuins

2019
Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases.
    Nutritional neuroscience, 2021, Volume: 24, Issue:5

    Topics: Animals; Humans; Mitochondria; NAD; Neurodegenerative Diseases

2021
Sirtuin deacetylases in neurodegenerative diseases of aging.
    Cell research, 2013, Volume: 23, Issue:6

    Topics: Aging; Caloric Restriction; Energy Metabolism; Histone Deacetylases; Humans; NAD; Neurodegenerative Diseases; Sirtuins

2013
NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases.
    Current topics in medicinal chemistry, 2013, Volume: 13, Issue:23

    Topics: Humans; Metabolic Diseases; NAD; Neoplasms; Neurodegenerative Diseases

2013
Coenzyme A, more than 'just' a metabolic cofactor.
    Biochemical Society transactions, 2014, Volume: 42, Issue:4

    Topics: Animals; Coenzyme A; Humans; NAD; Neurodegenerative Diseases; Phosphotransferases (Alcohol Group Acceptor)

2014
C-terminal binding proteins: central players in development and disease.
    Biomolecular concepts, 2014, Volume: 5, Issue:6

    Topics: Alcohol Oxidoreductases; Animals; Apoptosis; Cell Survival; Co-Repressor Proteins; DNA-Binding Proteins; Growth and Development; Humans; NAD; Neoplasms; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Oxidation-Reduction; Protein Conformation; Protein Processing, Post-Translational; Transcriptional Activation

2014
NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus.
    Cell metabolism, 2015, Jul-07, Volume: 22, Issue:1

    Topics: Aging; Animals; Cell Nucleus; Energy Metabolism; Homeostasis; Humans; Metabolic Diseases; Mitochondria; Molecular Targeted Therapy; NAD; Neoplasms; Neurodegenerative Diseases; Poly(ADP-ribose) Polymerases; Sirtuins

2015
NAD⁺ in aging, metabolism, and neurodegeneration.
    Science (New York, N.Y.), 2015, Dec-04, Volume: 350, Issue:6265

    Topics: Aging; Biosynthetic Pathways; Diabetes Mellitus, Type 2; DNA Damage; Fatty Liver; Humans; Mitochondria; NAD; Neurodegenerative Diseases; Obesity; Oxidation-Reduction; Poly(ADP-ribose) Polymerases; Sirtuins

2015
Molecular mechanisms in the initiation phase of Wallerian degeneration.
    The European journal of neuroscience, 2016, Volume: 44, Issue:4

    Topics: Animals; Axons; Humans; NAD; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Wallerian Degeneration

2016
Neurodegeneration in accelerated aging.
    Danish medical journal, 2016, Volume: 63, Issue:11

    Topics: Aging, Premature; Animals; Ataxia Telangiectasia; Bloom Syndrome; Cockayne Syndrome; DNA Repair; Dyskeratosis Congenita; Fanconi Anemia; Humans; Mitochondria; Mitophagy; NAD; Neurodegenerative Diseases; Poly(ADP-ribose) Polymerases; Progeria; Rothmund-Thomson Syndrome; Sirtuin 1; Telomere Shortening; Werner Syndrome; Xeroderma Pigmentosum

2016
Mitochondrial Sirtuins and Molecular Mechanisms of Aging.
    Trends in molecular medicine, 2017, Volume: 23, Issue:4

    Topics: Aging; Animals; Hearing Loss; Humans; Mitochondria; NAD; Neurodegenerative Diseases; Protein Interaction Maps; Sirtuins; Stress, Physiological

2017
Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies.
    Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:11

    Topics: Animals; Brain; Glutamic Acid; Humans; Kynurenic Acid; Mitochondrial Diseases; NAD; Neurodegenerative Diseases; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinolinic Acid; Tryptophan

2009
Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
    Current opinion in investigational drugs (London, England : 2000), 2010, Volume: 11, Issue:10

    Topics: Alzheimer Disease; Drug Delivery Systems; Group III Histone Deacetylases; Histone Deacetylases; Humans; Longevity; Metabolic Diseases; NAD; Neurodegenerative Diseases; Saccharomyces cerevisiae; Sirtuins

2010
Mitochondrial dysfunction and nicotinamide dinucleotide catabolism as mechanisms of cell death and promising targets for neuroprotection.
    Journal of neuroscience research, 2011, Volume: 89, Issue:12

    Topics: ADP-ribosyl Cyclase 1; Animals; Cell Death; Humans; Metabolism; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; NAD; Neurodegenerative Diseases; Neuroprotective Agents

2011
NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns.
    Redox report : communications in free radical research, 2012, Volume: 17, Issue:1

    Topics: Aging; Animals; Cell Death; Cell Membrane; DNA Repair; Energy Metabolism; Enzyme Activation; Humans; Kynurenine; Mammals; NAD; Neurodegenerative Diseases; Oxidative Stress; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Sirtuins

2012
Glial hemichannels and their involvement in aging and neurodegenerative diseases.
    Reviews in the neurosciences, 2012, Jan-26, Volume: 23, Issue:2

    Topics: Adenosine Triphosphate; Aging; Astrocytes; Calcium; Cannabinoids; Central Nervous System; Connexin 43; Connexins; Dinoprostone; Glucose; Glutamic Acid; Humans; Inflammation; Interleukin-1beta; Ion Channels; NAD; Nerve Degeneration; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Oligodendroglia; Signal Transduction; Tumor Necrosis Factor-alpha

2012
Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress.
    Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2005, Dec-29, Volume: 360, Issue:1464

    Topics: Citric Acid Cycle; Humans; Ketoglutarate Dehydrogenase Complex; Mitochondria; NAD; Neurodegenerative Diseases; Oxidative Stress; Reactive Oxygen Species

2005
Sirtuins in aging and age-related disease.
    Cell, 2006, Jul-28, Volume: 126, Issue:2

    Topics: ADP Ribose Transferases; Aging; Animals; Diabetes Mellitus; Eukaryotic Cells; Histone Deacetylases; Humans; Models, Biological; NAD; Neoplasms; Neurodegenerative Diseases; Sirtuins

2006
NAD+ metabolism in health and disease.
    Trends in biochemical sciences, 2007, Volume: 32, Issue:1

    Topics: ADP Ribose Transferases; ADP-ribosyl Cyclase; Aging; Animals; Candida glabrata; Candidiasis; Humans; Lipids; NAD; Neurodegenerative Diseases; Niacinamide; Poly(ADP-ribose) Polymerases; Sirtuins

2007
Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery.
    Expert opinion on therapeutic targets, 2007, Volume: 11, Issue:5

    Topics: Acrylamides; Adenosine Diphosphate Ribose; Aging; Animals; Antineoplastic Agents; Autoimmune Diseases; Clinical Trials, Phase II as Topic; Cyclic ADP-Ribose; DNA Damage; Drug Design; Enzyme Inhibitors; Humans; Kynurenine; Mice; NAD; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents; Piperidines; Poly Adenosine Diphosphate Ribose; Signal Transduction; Sirtuins; Tryptophan

2007
Sirtuins: the 'magnificent seven', function, metabolism and longevity.
    Annals of medicine, 2007, Volume: 39, Issue:5

    Topics: Animals; Caenorhabditis elegans; Caloric Restriction; Drosophila melanogaster; Energy Metabolism; Histone Deacetylases; Humans; Longevity; Mammals; NAD; Neurodegenerative Diseases; Saccharomyces cerevisiae; Sirtuins

2007
Tryptophan, adenosine, neurodegeneration and neuroprotection.
    Metabolic brain disease, 2007, Volume: 22, Issue:3-4

    Topics: Adenosine; Animals; Hepatic Encephalopathy; Humans; Kynurenine; NAD; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Quinolinic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Purinergic P1; Tryptophan

2007
NAD+ and NADH in neuronal death.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2007, Volume: 2, Issue:3

    Topics: Animals; Cell Death; Humans; NAD; Neurodegenerative Diseases; Neurons

2007

Trials

1 trial(s) available for nad and Degenerative Diseases, Central Nervous System

ArticleYear
The acute effect of different NAD
    Free radical biology & medicine, 2023, Aug-20, Volume: 205

    Topics: Humans; Metabolic Diseases; NAD; Neurodegenerative Diseases; Niacin; Niacinamide; Nicotinamide Mononucleotide

2023

Other Studies

19 other study(ies) available for nad and Degenerative Diseases, Central Nervous System

ArticleYear
Drug Value of Drynariae Rhizoma Root-Derived Extracellular Vesicles for Neurodegenerative Diseases Based on Proteomics and Bioinformatics.
    Plant signaling & behavior, 2022, 12-31, Volume: 17, Issue:1

    Topics: Computational Biology; Extracellular Vesicles; Humans; NAD; Neurodegenerative Diseases; Oxidoreductases; Plant Roots; Polypodiaceae; Proteomics; Quinones

2022
Nutritional Epigenetics: How Metabolism Epigenetically Controls Cellular Physiology, Gene Expression and Disease.
    Sub-cellular biochemistry, 2022, Volume: 100

    Topics: Chromatin; Epigenesis, Genetic; Gene Expression; Histones; Humans; Ketoglutaric Acids; NAD; Neurodegenerative Diseases

2022
Severe NAD(P)HX Dehydratase (NAXD) Neurometabolic Syndrome May Present in Adulthood after Mild Head Trauma.
    International journal of molecular sciences, 2023, Feb-10, Volume: 24, Issue:4

    Topics: Adult; Brain Concussion; Brain Diseases, Metabolic; Child; Child, Preschool; Humans; Hydro-Lyases; Mitochondria; NAD; Neurodegenerative Diseases; Proteomics

2023
Study of NAD-interacting proteins highlights the extent of NAD regulatory roles in the cell and its potential as a therapeutic target.
    Journal of integrative bioinformatics, 2023, Jun-01, Volume: 20, Issue:2

    Topics: Humans; NAD; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction; Signal Transduction

2023
Advancing nutrition science to meet evolving global health needs.
    European journal of nutrition, 2023, Volume: 62, Issue:Suppl 1

    Topics: Child; Choline; Chronic Disease; Dietary Supplements; Global Health; Humans; Infant; NAD; Neurodegenerative Diseases; Nutritional Sciences; Xanthophylls

2023
NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses.
    Brain : a journal of neurology, 2020, 02-01, Volume: 143, Issue:2

    Topics: Humans; Hydro-Lyases; NAD; Neurodegenerative Diseases

2020
Deletion of Topoisomerase 1 in excitatory neurons causes genomic instability and early onset neurodegeneration.
    Nature communications, 2020, 04-23, Volume: 11, Issue:1

    Topics: Animals; Apoptosis; Cerebral Cortex; DNA Damage; DNA Topoisomerases, Type I; Genomic Instability; Hippocampus; Inflammation; Mice; Mice, Knockout; Mortality, Premature; Motor Activity; Mutation; NAD; Neurodegenerative Diseases; Neurons; Niacinamide; Poly (ADP-Ribose) Polymerase-1; Pyridinium Compounds

2020
Reply: NAD(P)HX dehydratase protein-truncating mutations are associated with neurodevelopmental disorder exacerbated by acute illness.
    Brain : a journal of neurology, 2020, 07-01, Volume: 143, Issue:7

    Topics: Acute Disease; Humans; Hydro-Lyases; Mutation; NAD; Neurodegenerative Diseases; Neurodevelopmental Disorders

2020
NAD(P)HX dehydratase protein-truncating mutations are associated with neurodevelopmental disorder exacerbated by acute illness.
    Brain : a journal of neurology, 2020, 07-01, Volume: 143, Issue:7

    Topics: Acute Disease; Humans; Hydro-Lyases; Mutation; NAD; Neurodegenerative Diseases; Neurodevelopmental Disorders

2020
NAD metabolism in aging and cancer.
    Experimental biology and medicine (Maywood, N.J.), 2020, Volume: 245, Issue:17

    Topics: Aging; Animals; Humans; NAD; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction; Poly Adenosine Diphosphate Ribose

2020
NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses.
    Brain : a journal of neurology, 2019, 01-01, Volume: 142, Issue:1

    Topics: Child, Preschool; Computer Simulation; Female; Fever; Fibroblasts; Genetic Vectors; Humans; Hydro-Lyases; Infant; Kinetics; Lentivirus; Male; Mitochondria; Mutation; NAD; Neurodegenerative Diseases; Primary Cell Culture; Whole Genome Sequencing

2019
Synapto-protective drugs evaluation in reconstructed neuronal network.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Amides; Amino Acid Chloromethyl Ketones; Animals; Axons; Dendrites; Embryo, Mammalian; Enzyme Inhibitors; Mice; Microfluidics; Microscopy, Fluorescence; Models, Neurological; NAD; Nerve Net; Neurodegenerative Diseases; Primary Cell Culture; Pyridines; Resveratrol; Stilbenes; Synapses

2013
Reversing neurodegenerative hearing loss.
    Lab animal, 2015, Volume: 44, Issue:1

    Topics: Animals; Disease Models, Animal; Hearing Loss; Humans; Mice; Mice, Knockout; NAD; Neurodegenerative Diseases; Niacinamide; Pyridinium Compounds; Sirtuin 3

2015
Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
    BMC neurology, 2015, Mar-01, Volume: 15

    Topics: Alzheimer Disease; Animals; Brain; Female; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Nicotinamide Mononucleotide; Oxygen Consumption

2015
Roles of glucose in photoreceptor survival.
    The Journal of biological chemistry, 2011, Oct-07, Volume: 286, Issue:40

    Topics: Acetylglucosamine; Adenosine Triphosphate; Animals; Autophagy; Cell Death; Cell Survival; Gas Chromatography-Mass Spectrometry; Glucose; Lactic Acid; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Neurodegenerative Diseases; Neurons; Oxygen Consumption; Photoreceptor Cells, Vertebrate; Retina

2011
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
    PloS one, 2012, Volume: 7, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Body Weight; Cognition Disorders; Cytosol; Disease Models, Animal; Dopamine; Female; Genotype; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Neurons; Parkinson Disease; Time Factors; Tyrosine 3-Monooxygenase

2012
Neuroscience. NAD to the rescue.
    Science (New York, N.Y.), 2004, Aug-13, Volume: 305, Issue:5686

    Topics: Animals; Axons; Cell Nucleus; Cell Survival; Cells, Cultured; Ganglia, Spinal; Mice; Mutation; NAD; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Nicotinamide-Nucleotide Adenylyltransferase; RNA, Small Interfering; Sirtuin 1; Sirtuins; Ubiquitin-Protein Ligases; Wallerian Degeneration

2004
The role of the carboxamide group in nicotinamide adenine dinucleotide in relation to hydride transfer: the reduced form of the dinucleotide as remedy in the modulation of neurotransmission.
    Nucleosides, nucleotides & nucleic acids, 2005, Volume: 24, Issue:5-7

    Topics: Adenine Nucleotides; Amides; Animals; Carbon; Dinucleoside Phosphates; Humans; Hydrogen; Kinetics; Molecular Conformation; NAD; Neurodegenerative Diseases; Neurons; Nitrogen; Nucleotides; Protein Folding; Stereoisomerism; Synaptic Transmission

2005
Membrane permeability of redox active metal chelators: an important element in reducing hydroxyl radical induced NAD+ depletion in neuronal cells.
    Neuroscience research, 2007, Volume: 57, Issue:3

    Topics: Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Cytoplasm; Humans; Hydroxyl Radical; Intracellular Fluid; Iron Chelating Agents; Membrane Lipids; NAD; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress

2007